SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
76 hedge funds and large institutions have $209M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+19
Holders Change %
+33.33%
% of All Funds
1.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
31
Reduced
10
Closed
7
Calls
$147K
Puts
$270K
Net Calls
-$123K
Net Calls Change
-$344K
Top Buyers
| 1 |
BlackRock
New York
|
+$6.68M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.01M |
| 3 |
Millennium Management
New York
|
+$2.16M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.93M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.7M |
